Compare BIO-TECHNE Corp (TECH) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Zoom Video Communications, Inc. — how do they compare? BIO-TECHNE Corp trades at $71.58 (market cap $11.24B), while Zoom Video Communications, Inc. trades at $104.99 (market cap $31.10B). The key difference: Zoom Video Communications, Inc. is far larger — about 2.8× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals.
| TECH | ZM | |
|---|---|---|
Market Cap | $11.24B | $31.10B |
Sector | Health | Technology |
52-Week High | $72.29 | $111.88 |
52-Week Low | $43.31 | $69.96 |
Enterprise Value | $11.32B | $23.44B |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zoom Communications (ZM) trades at $107.20, up 2.58% today, with a bullish technical signal from moving averages and a consensus analyst price target of $118.79. The stock shows strong profitability with a net income margin of 41.99% and ROE of 21.95%, supported by recent earnings beats. However, insider selling and mixed oscillators suggest caution amid overbought conditions.
Outlook: ZM offers growth potential with solid fundamentals and AI-driven product expansions, but risks include competitive pressures and volatile cash flows. Investors should weigh the high valuation (P/E 15.62) against earnings consistency and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
